Comparison of the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616; Org 25969) in Elderly Participants With Adult Participants (MK-8616-029)
PHASE3CompletedINTERVENTIONAL
Enrollment
162
Participants
Timeline
Start Date
December 29, 2005
Primary Completion Date
October 20, 2006
Study Completion Date
October 20, 2006
Conditions
Anesthesia, General
Interventions
DRUG
Sugammadex
DRUG
Rocurium
intravenous (IV) single bolus dose of 0.6 mg.kg-1
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT00474617 - Comparison of the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616; Org 25969) in Elderly Participants With Adult Participants (MK-8616-029) | Biotech Hunter | Biotech Hunter